Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes

Human metapneumovirus (HMPV) is a leading cause of acute respiratory tract infections in infants and children. Currently, no approved HMPV vaccine is available. We developed a novel recombinant influenza virus, which carried partial HMPV F protein (HMPV-F) epitopes, utilizing reverse genetics. The n...

Full description

Bibliographic Details

Published in:	Virulence
Main Authors:	Fang Sun, Guanglin Lei, Chongyu Tian, Zhifang Bai, Changqing Bai, Yufeng Li, Zhuoya Deng, Hao Yang, Cong Li, Zhongpeng Zhao, Yan Niu, Penghui Yang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Influenza virus reverse genetics HMPV HMPV vaccine
Online Access:	https://www.tandfonline.com/doi/10.1080/21505594.2023.2284515